Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and one has given a strong buy recommendation to the company.
Separately, William Blair restated an “outperform” rating on shares of Stevanato Group in a research report on Monday, June 30th.
View Our Latest Stock Report on Stevanato Group
Stevanato Group Stock Performance
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the stock. Conestoga Capital Advisors LLC increased its holdings in shares of Stevanato Group by 1.3% in the first quarter. Conestoga Capital Advisors LLC now owns 8,189,926 shares of the company’s stock valued at $167,238,000 after buying an additional 106,930 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in shares of Stevanato Group by 13.3% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 3,744,714 shares of the company’s stock valued at $76,468,000 after acquiring an additional 439,722 shares in the last quarter. TimesSquare Capital Management LLC grew its holdings in shares of Stevanato Group by 2.1% during the 1st quarter. TimesSquare Capital Management LLC now owns 3,358,966 shares of the company’s stock valued at $68,590,000 after acquiring an additional 70,437 shares in the last quarter. Artisan Partners Limited Partnership boosted its holdings in Stevanato Group by 20.0% in the second quarter. Artisan Partners Limited Partnership now owns 2,733,782 shares of the company’s stock worth $66,786,000 after purchasing an additional 455,323 shares in the last quarter. Finally, Bamco Inc. NY boosted its holdings in Stevanato Group by 2.1% in the second quarter. Bamco Inc. NY now owns 1,888,050 shares of the company’s stock worth $46,125,000 after purchasing an additional 39,528 shares in the last quarter.
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Stories
- Five stocks we like better than Stevanato Group
- Breakout Stocks: What They Are and How to Identify Them
- Ride the Luxury Retail Wave with These 3 High-End Brand Stocks
- What is the Dow Jones Industrial Average (DJIA)?
- Wall Street Quietly Bets Big on These Chinese Tech Giants
- Why Invest in 5G? How to Invest in 5G Stocks
- Meta’s $600B U.S. Investment: Bearish or Bullish for Shares?
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.